Skip to content
beroni logo newberoni logo new
  • About
    • About Beroni
    • Our History
    • Board of Directors
    • Management Team
    • Vision, Mission and Values
  • R&D
    • R&D
    • PENAO
      • PENAO Introduction
      • About
      • Board & Senior Management
      • Asset Protection
      • Research & Development​
      • Value Proposition
  • Core Businesses
    • Cell Therapies
    • Anti-Cancer Drugs
    • Infectious Diseases
    • Infectious Diseases – COVID-19
    • E-commerce
  • Products
    • By Beroni China
    • By Beroni USA
    • By Beroni Biotech
  • Investors
    • Announcements
    • Financial Information
    • Corporate Governance
    • Stock Information
    • Globenewswire Press Releases
    • Medtech Outlook
    • Research Report
    • COVID-19 Vaccines Overview
    • FAQs
  • News
  • Contact
  • English
Menu Close
  1. Home>
  2. 2018>
  3. December>
  4. 29>
  5. 2018>
  6. New Year Address of Beroni Group
You are currently viewing New Year Address of Beroni Group

New Year Address of Beroni Group

  • Post author:admin
  • Post published:2018-12-29
  • Post category:2018

You Might Also Like

Read more about the article The International Symposium for Infection & Immunity will be held

The International Symposium for Infection & Immunity will be held

2018-06-11
Read more about the article Beroni Group and UNSW Signing Ceremony and Press Conference for Phase II development of anti-cancer drug PENAO

Beroni Group and UNSW Signing Ceremony and Press Conference for Phase II development of anti-cancer drug PENAO

2018-03-29
Read more about the article Japans former Prime Minister, Yukio Hatoyama visited Beroni Group

Japans former Prime Minister, Yukio Hatoyama visited Beroni Group

2018-01-23

Search Article

Arrange by Year

  • 2017 (10)
  • 2018 (24)
  • 2019 (25)
  • 2020 (17)
  • 2021 (11)
  • 2022 (8)
  • 2023 (6)
  • 2024 (1)

What’s New

  • New Year Greetings from Mr. Jacky Zhang！
  • Wish You Happy New Year！
  • Beroni Pharmaceutical has received approval from the Environmental Impact Report Form of the Zhuhai Ecological Environment Bureau
  • Beroni Group was Invited to Attend the 4th World-Class Enterprises R&D and Innovation Management Forum
  • Successful Conclusion to the Conference of FET

Beroni Group is an international biotechnological company listed on the National Stock Exchange (Australia) and traded on the OTC markets in the USA with business presence in Australia, China, Japan and the USA. It currently has four core businesses – research and development of new drugs and clinical trial, immune cell therapy including gene detection and diagnosis, immunotherapy for cancer treatment, diagnosis of infectious diseases and e-commerce based on the Internet sales of pharmaceutical, healthcare and cosmetic products.

About

  • About Beroni
  • Our History
  • Board of Directors
  • Management Team
  • Vision, Mission, and Values

Core Businesses

  • Cell Therapy
  • Anti-Cancer Drugs
  • Infectious Diseases
  • E-Commerce

Products

  • By Beroni China
  • By Beroni Japan
  • By Beroni USA

Copyrights© Beroni Group 2019 | All rights reserved |

website by chase e-Design

Close Menu